Style | Citing Format |
---|---|
MLA | Gholami L, et al.. "Selective Cellular Uptake and Cytotoxicity of Curcumin-Encapsulated Spc and Hspc Liposome Nanoparticles on Human Bladder Cancer Cells." Current Pharmaceutical Design, vol. 29, no. 13, 2023, pp. 1046-1058. |
APA | Gholami L, Momtaziborojeni AA, Malaekehnikouei B, Nikfar B, Amanolahi F, Mohammadi A, Oskuee RK (2023). Selective Cellular Uptake and Cytotoxicity of Curcumin-Encapsulated Spc and Hspc Liposome Nanoparticles on Human Bladder Cancer Cells. Current Pharmaceutical Design, 29(13), 1046-1058. |
Chicago | Gholami L, Momtaziborojeni AA, Malaekehnikouei B, Nikfar B, Amanolahi F, Mohammadi A, Oskuee RK. "Selective Cellular Uptake and Cytotoxicity of Curcumin-Encapsulated Spc and Hspc Liposome Nanoparticles on Human Bladder Cancer Cells." Current Pharmaceutical Design 29, no. 13 (2023): 1046-1058. |
Harvard | Gholami L et al. (2023) 'Selective Cellular Uptake and Cytotoxicity of Curcumin-Encapsulated Spc and Hspc Liposome Nanoparticles on Human Bladder Cancer Cells', Current Pharmaceutical Design, 29(13), pp. 1046-1058. |
Vancouver | Gholami L, Momtaziborojeni AA, Malaekehnikouei B, Nikfar B, Amanolahi F, Mohammadi A, et al.. Selective Cellular Uptake and Cytotoxicity of Curcumin-Encapsulated Spc and Hspc Liposome Nanoparticles on Human Bladder Cancer Cells. Current Pharmaceutical Design. 2023;29(13):1046-1058. |
BibTex | @article{ author = {Gholami L and Momtaziborojeni AA and Malaekehnikouei B and Nikfar B and Amanolahi F and Mohammadi A and Oskuee RK}, title = {Selective Cellular Uptake and Cytotoxicity of Curcumin-Encapsulated Spc and Hspc Liposome Nanoparticles on Human Bladder Cancer Cells}, journal = {Current Pharmaceutical Design}, volume = {29}, number = {13}, pages = {1046-1058}, year = {2023} } |
RIS | TY - JOUR AU - Gholami L AU - Momtaziborojeni AA AU - Malaekehnikouei B AU - Nikfar B AU - Amanolahi F AU - Mohammadi A AU - Oskuee RK TI - Selective Cellular Uptake and Cytotoxicity of Curcumin-Encapsulated Spc and Hspc Liposome Nanoparticles on Human Bladder Cancer Cells JO - Current Pharmaceutical Design VL - 29 IS - 13 SP - 1046 EP - 1058 PY - 2023 ER - |